Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018)

Historic Liabilities from Discontinued Operations for Sunshine Biopharma (SBFM) over the last 2 years, with Q4 2018 value amounting to $103732.0.

  • Sunshine Biopharma's Liabilities from Discontinued Operations changed N/A to $103732.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $103732.0, marking a year-over-year change of. This contributed to the annual value of $103732.0 for FY2018, which is N/A changed from last year.
  • As of Q4 2018, Sunshine Biopharma's Liabilities from Discontinued Operations stood at $103732.0.
  • Sunshine Biopharma's 5-year Liabilities from Discontinued Operations high stood at $103732.0 for Q4 2018, and its period low was $103732.0 during Q4 2018.